EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudie

Lobectomy Versus Sub-lobectomy for Clinical Stage IA (≤2 cm) Lung Squamous Cell Carcinoma with Tumour Spread through Air Spaces: A Multi-Centre Retrospective Study

Hanbo Pan, Hang Chen, Zhen Ge, Yu Tian iD, Weicheng Kong, Wanyu Li, Junwei Ning, Zhiyuan Bao, Zhizhuo Dai, Zhongjie Chen, Difan Zhang, Liang Fang und 9 weitere

European Journal of Cardio-Thoracic Surgery · 2025

DOI: 10.1093/ejcts/ezaf224 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Hanbo Pan und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgical Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Sha…. Hauptthemen laut MEDLINE: Pneumonectomy, Lung Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Nature Science Foundation of China, Natural Science Foundation of Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The efficacy of sub-lobectomy for clinical IA (tumours ≤2 cm) lung squamous cell carcinoma with tumour spread through air spaces (STAS) remains unknown. This study compares long-term survival outcomes between sub-lobectomy and lobectomy, aiming to offer pivotal evidence for optimizing resection strategies for clinical IA STAS-positive squamous cell carcinoma patients.

Methods

Consecutive clinical IA STAS-positive squamous cell carcinoma patients undergoing surgery between 2010 and 2020 at 7 high-volume institutions across 5 Chinese cities were retrospectively reviewed. The primary end-point was overall survival, and the secondary end-point was recurrence-free survival. Propensity-score matching was employed to mitigate selection bias.

Results

A total of 870 patients were included, and propensity-score matching yielded 476 and 238 cases in the lobe and sub-lobe groups, respectively. Over an estimated median follow-up of 6.51 years, lobectomy significantly improved overall survival (hazard ratio [95% confidence interval] = 0.598 [0.447-0.761], P < .001) and recurrence-free survival (hazard ratio [95% confidence interval] = 0.572 [0.449-0.733], P < .001), and reduced postoperative mortality (30.7% vs 40.3%, P = .010) and recurrence (39.3% vs 55.0%, P < .001) incidences compared to sub-lobectomy. Further subgroup analysis revealed that lobectomy improved survival outcomes over sub-lobectomy in younger (age <70 years) and clinical IA2 sub-cohorts, while the 2 approaches yielded comparable survival outcomes for elderly (age ≥70 years) and clinical IA1 sub-cohorts.

Conclusions

Lobectomy improved survival outcomes over sub-lobectomy for clinical IA STAS-positive squamous cell carcinoma and thus might be preferred for clinical IA squamous cell carcinoma patients with highly suspected STAS. The prognostic benefits of lobectomy may be discriminated by age and clinical stage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PneumonectomyLung NeoplasmsCarcinoma, Squamous CellHumansRetrospective StudiesMaleFemaleMiddle AgedAgedNeoplasm StagingChinaNeoplasm InvasivenessTreatment Outcome

Stichwörter der Autor:innen

lobectomylung squamous cell carcinomaoverall survivalrecurrence-free survivalspread through air spacessub-lobectomy

Autor:innen und Institutionen

  • Department of Thoracic Surgical Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
  • Department of Cardiothoracic Surgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo 315040, China.
  • Department of Cardiothoracic Surgery, The First Affiliated Hospital of Ningbo University, Ningbo 315020, China.
  • Department of Thoracic Surgery, Putuo District People's Hospital, Zhoushan 316100, China.
  • Department of Integrated Traditional Chinese and Western Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China.
  • Department of Thoracic Surgery, Shanghai Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200050, China.

ORCID-Profile: Yu Tian, Qingquan Luo

Förderung

  • National Nature Science Foundation of China
  • Natural Science Foundation of Shanghai

Zitieren

APA

Pan, H., Chen, H., Ge, Z., Tian, Y., Kong, W., Li, W., Ning, J., Bao, Z., Dai, Z., Chen, Z., Zhang, D., Fang, L., Zheng, M., Ruan, G., Wang, H., Zhang, M., Yin, H., Huang, J., Zhou, C., …, & Luo, Q. (2025). Lobectomy Versus Sub-lobectomy for Clinical Stage IA (≤2 cm) Lung Squamous Cell Carcinoma with Tumour Spread through Air Spaces: A Multi-Centre Retrospective Study. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf224

Vancouver

Pan H, Chen H, Ge Z, Tian Y, Kong W, Li W, et al. Lobectomy Versus Sub-lobectomy for Clinical Stage IA (≤2 cm) Lung Squamous Cell Carcinoma with Tumour Spread through Air Spaces: A Multi-Centre Retrospective Study. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf224

BibTeX
@article{Pan2025,
  author = {Pan, Hanbo and Chen, Hang and Ge, Zhen and Tian, Yu and Kong, Weicheng and Li, Wanyu and Ning, Junwei and Bao, Zhiyuan and Dai, Zhizhuo and Chen, Zhongjie and Zhang, Difan and Fang, Liang and Zheng, Min and Ruan, Guomo and Wang, Hui and Zhang, Ming and Yin, Hui and Huang, Jia and Zhou, Chengwei and Xu, Guodong and Luo, Qingquan},
  title = {Lobectomy Versus Sub-lobectomy for Clinical Stage IA (≤2 cm) Lung Squamous Cell Carcinoma with Tumour Spread through Air Spaces: A Multi-Centre Retrospective Study},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2025},
  doi = {10.1093/ejcts/ezaf224}
}
Kostenlos starten →